Info Obat dan Regulator Obat Dunia

F
The Elderberry Co., LLC - 608837 - 09/08/2020
Replies
0
Views
312
FDA
F
F
Development & Approval Process | Drugs
Replies
0
Views
261
FDA
F
E
PRIME enables earlier availability of life-changing medicines, , 03/03/2022
Replies
0
Views
291
EMA
E
E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 March 2022, PRAC, 11/03/2022
Replies
0
Views
285
EMA
E
E
EMA Management Board elects Lorraine Nolan as chair, MB, 17/03/2022
Replies
0
Views
313
EMA
E
E
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 March 2022, CVMP, 18/03/2022
Replies
0
Views
312
EMA
E
E
EMA Management Board: highlights of March 2022 meeting, MB, 18/03/2022
Replies
0
Views
284
EMA
E
E
EMA recommends authorisation of COVID-19 medicine Evusheld, CHMP, 24/03/2022
Replies
0
Views
255
EMA
E
E
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022, CHMP, 25/03/2022
Replies
0
Views
318
EMA
E
E
New gene therapy to treat adult patients with multiple myeloma, CHMP, 25/03/2022
Replies
0
Views
312
EMA
E
E
EMA starts rolling review of COVID-19 Vaccine HIPRA (PHH-1V), CHMP, 29/03/2022
Replies
0
Views
274
EMA
E
E
EU recommendations for 2022-2023 seasonal flu vaccine composition, CHMP, 29/03/2022
Replies
0
Views
255
EMA
E
E
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 2022, CVMP, 21/02/2022
Replies
0
Views
378
EMA
E
F
FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States
Replies
0
Views
276
FDA
F
F
Family Dollar Stores Issues Voluntary Recall of Certain FDA-Regulated Products in Six States Including Drugs, Devices, Cosmetics, Foods
Replies
0
Views
272
FDA
F
F
FDA Roundup: February 18, 2022
Replies
0
Views
283
FDA
F
F
FDA adds Boxed Warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines
Replies
0
Views
283
FDA
F
F
Electronic Registration and Listing Compliance Program
Replies
0
Views
293
FDA
F
F
Public Meeting: Final Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act - 03/22/2022
Replies
0
Views
306
FDA
F
F
2020 Meeting Materials, Peripheral and Central Nervous System Drugs Advisory Committee
Replies
0
Views
218
FDA
F
You must log in or register to post here.
Top